Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers were recorded at baseline, at 2 months, and at 6 months, while radiographic and at 6 months was calculated on standardized radiographs by using the image analysis software. Results: Mean PD reduction and mean PAL gain were found to be greater in the ALN group than in the placebo group, both smokers. Thus, 1% ALN, along with SRP, is effective in the treatment of chronic periodontitis in smokers.
Introduction main aetiological factors in periodontal diseases 10 .
Additionally, extensive researches suggest that host- Evidence from cross-sectional and case-control studies in various populations and an abundant number of reviews on the subject have shown that adult smokers are about two to four times more likely to have periodontitis than nonsmokers. Previous studies indicated that smokers did not respond to nonsurgical periodontal therapy 2, 13 . Additionally, smokers showed less probing depth reduction and attachment gain, compared to nonsmokers, for periodontal surgical treatment 11, 23 .
Considering the abovementioned facts, the current gel as local drug delivery along with scaling and root planing (SRP) for the treatment of intrabony defects among smokers with chronic periodontitis.
Material and methods
Source of data In the ALN group, sites were treated with SRP followed by 1% ALN gel (10 mg/ml) local drug delivery, while in the placebo group sites were treated with SRP followed by placebo gel placement. Subjects were blinded for allocation into ALN or placebo group. SRP was performed at baseline until the root surface was Gujarat, India) was dissolved in a required amount of distilled water to achieve 1% ALN concentration.
A weighed quantity of carbopol 934P (2% w/w) was taken and added to the distilled water. The mixture was gradually stirred and carbopol was allowed to soak for 2 h. 1% triethanolamine was added to neutralize the carbopol solution and to form the gel. The pH was adjusted to 6.8. Finally, the required amount of methylparaben (0.1%) and propylparaben (0.05%)
were dissolved in ethanol and added to the gel. The placebo gel was prepared by the abovementioned procedure without adding the active ingredient (ALN).
Local drug delivery
The prepared ALN gel (10 mg/ml) was dispensed into the periodontal pockets with intrabony defects using a syringe with a blunt cannula. Patients were instructed not to use forceful brushing or interdental aids at the treated sites until the appointment after 2 months and to avoid chewing sticky or hard food.
Statistical analysis
Power analysis calculations were performed before the study was initiated. To achieve 90% power and detect mean differences of the clinical parameters between groups, 30 sites in each group were required. , the improvement in clinical parameters in this study was higher in AgP subjects but lower in subjects subjects but lower in AgP subjects. PD reduction was as reported in previous study 26 , but greater compared observed in previous study 27 . Similarly Compared to a systemic regimen, local delivery may and patient compliance, as also reported in previous study 19, 26, 27 . after 6 months from baseline, while ALN was found at 1 month and absent at 2 months, as reported in a previous study 26 . This can be explained by the release of BPs from bounded bone mineral during bone resorption by osteoclasts. This could lead to a localized accumulation of BPs, which could directly perturb osteoclastic activity or indirectly target osteoblasts and macrophages, resulting in decreased osteoclastic chemotaxis and activity 6 . Carbopol was used as vehicle for preparation of ALN gel in this study, which is considered to provide intimate contact and prolong the residing time of a dosage form in the periodontal commonly referred as mucoadhesion, after LDD 14, 21 .
Conclusion improvement in periodontal clinical parameters in
smokers with chronic periodontitis compared to control subjects. 1% ALN can be used as a local drug delivery system along with SRP for nonsurgical management of periodontitis.
